OppenheimerFunds’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $97.9M | Buy |
3,644,406
+15,830
| +0.4% | +$425K | 0.12% | 173 |
|
|
2018
Q4 | $58.7M | Sell |
3,628,576
-85,390
| -2% | -$1.38M | 0.08% | 240 |
|
|
2018
Q3 | $77.1M | Sell |
3,713,966
-744,410
| -17% | -$15.5M | 0.09% | 245 |
|
|
2018
Q2 | $68.1M | Buy |
4,458,376
+112,430
| +3% | +$1.72M | 0.08% | 268 |
|
|
2018
Q1 | $97.7M | Sell |
4,345,946
-467,153
| -10% | -$10.5M | 0.12% | 186 |
|
|
2017
Q4 | $145M | Sell |
4,813,099
-325,374
| -6% | -$9.8M | 0.18% | 144 |
|
|
2017
Q3 | $194M | Buy |
5,138,473
+63,873
| +1% | +$2.41M | 0.24% | 112 |
|
|
2017
Q2 | $142M | Buy |
5,074,600
+156,314
| +3% | +$4.36M | 0.17% | 150 |
|
|
2017
Q1 | $169M | Buy |
4,918,286
+170,289
| +4% | +$5.85M | 0.2% | 132 |
|
|
2016
Q4 | $137M | Sell |
4,747,997
-402,226
| -8% | -$11.6M | 0.17% | 148 |
|
|
2016
Q3 | $164M | Buy |
5,150,223
+158,572
| +3% | +$5.04M | 0.21% | 131 |
|
|
2016
Q2 | $162M | Buy |
4,991,651
+359,960
| +8% | +$11.7M | 0.21% | 125 |
|
|
2016
Q1 | $130M | Buy |
4,631,691
+703,256
| +18% | +$19.7M | 0.17% | 146 |
|
|
2015
Q4 | $140M | Buy |
3,928,435
+211,963
| +6% | +$7.56M | 0.18% | 136 |
|
|
2015
Q3 | $123M | Sell |
3,716,472
-63,326
| -2% | -$2.09M | 0.17% | 156 |
|
|
2015
Q2 | $158M | Buy |
3,779,798
+70,291
| +2% | +$2.94M | 0.18% | 145 |
|
|
2015
Q1 | $121M | Buy |
+3,709,507
| New | +$121M | 0.14% | 192 |
|